Radioiodine treatment of multinodular non-toxic goitre.
- 2 October 1993
- Vol. 307 (6908), 828-832
- https://doi.org/10.1136/bmj.307.6908.828
Abstract
OBJECTIVE--To investigate the long term effect of radioactive iodine on thyroid function and size in patients with non-toxic multinodular goitre. DESIGN--Consecutive patients with multinodular non-toxic goitre selected for radioactive iodine treatment and followed for a minimum of 12 months (median 48 months) after an intended dose of 3.7 MBq/g thyroid tissue corrected to a 100% uptake of iodine-131 in 24 hours. PATIENTS--69 patients with a growing multinodular non-toxic goitre causing local compression symptoms or cosmetic inconveniences. The treatment was chosen because of a high operative risk, previous thyroidectomy, or refusal to be operated on. MAIN OUTCOME MEASUREMENTS--Standard thyroid function variables and ultrasonically determined thyroid volume before treatment as well as 1, 2, 3, 6, and 12 months after treatment and then once a year. RESULTS--56 patients were treated with a single dose of 131I, 12 with two doses, and one with four doses. In 45 patients treated with one dose and remaining euthyroid the median thyroid volume was reduced from 73 (interquartile range 50-106) ml to 29 (23-48) ml at 24 months in the 39 patients in whom this was measured during follow up. The median reduction was 40 (22-48) ml (60% reduction, p < 0.0001), half of which occurred within three months. Patients treated with two doses as well as those developing hypothyroidism and hyperthyroidism had a significant reduction in thyroid volume. Eleven patients developed hypothyroidism (cumulative five year risk 22%, 95% confidence interval 4.8% to 38.4%). Side effects were few: three cases of hyperthyroidism and two cases of radiation thyroiditis. Only one patient was dissatisfied with the result; she was referred for operation six months after treatment. CONCLUSIONS--A substantial reduction in thyroid volume accompanied by a low incidence of hypothyroidism and few side effects makes the use of radioactive iodine an attractive alternative to surgery in selected cases of non-toxic multinodular goitre.Keywords
This publication has 23 references indexed in Scilit:
- Subtle changes in serum thyrotrophin (TSH) and sex-hormone-binding globulin (SHBG) levels during long-term follow-up after radioactive iodine in multinodular non-toxic goitre.Clinical Endocrinology, 1992
- Cancer Risk After Iodine-131 Therapy for HyperthyroidismJNCI Journal of the National Cancer Institute, 1991
- Comparison of placebo with L-thyroxine alone or with carbimazole for treatment of sporadic non-toxic goitreThe Lancet, 1990
- Reduction of size of thyroid with radioactive iodine in multinodular non-toxic goitre.BMJ, 1988
- Treatment of non-toxic multinodular goiter with radioactive iodineAmerican Journal Of Medicine, 1988
- Suppressive Therapy with Levothyroxine for Solitary Thyroid NodulesNew England Journal of Medicine, 1987
- Does prophylactic thyroxine treatment after operation for non-toxic goitre influence thyroid size?BMJ, 1987
- RADIOACTIVE IODINE FOR THYROTOXICOSISThe Lancet, 1986
- RECURRENCE OF NONTOXIC GOITRE WITH AND WITHOUT POSTOPERATIVE THYROXINE MEDICATIONClinical Endocrinology, 1984
- Ergebnisse der Radiojod-Verkleinerungstherapie euthyreoter Strumen*Deutsche Medizinische Wochenschrift (1946), 1964